Colorectal cancer (CRC) is the third most prevalent cancer worldwide, with nearly two million newly diagnosed cases each year. The survival of patients with CRC greatly depends on the cancer stage at the time of diagnosis, with worse prognosis for more advanced cases. Consequently, considerable effort has been directed towards improving population screening programs for early diagnosis and identifying prognostic markers that can better inform treatment strategies. In recent years, long non-coding RNAs (lncRNAs) have been recognized as promising molecules, with diagnostic and prognostic potential in many cancers, including CRC. Although large-scale genome and transcriptome sequencing surveys have identified many lncRNAs that are altered in C...
Colorectal cancer (CRC) is one of the most common malignancies in the world. Easier recurrence and m...
Colorectal cancer (CRC) is one of the most common cancers in humans and a leading cause of cancer-re...
Abstract Background Heterogeneity in colorectal cancer (CRC) patients provides novel strategies in c...
Colorectal cancer (CRC) is one of the most frequent causes of cancer-related death worldwide. The pr...
Altres ajuts: The authors thank Jesse R. Willis for his help in editing the manuscript. TG group ack...
Colorectal cancer (CRC) is the fourth most common cause of death worldwide. Surgery is usually the f...
Colorectal cancer (CRC) is the fourth most common cause of death worldwide. Surgery is usually the f...
Colorectal cancer (CRC) is one of the deadliest tumours, but its pathogenesis remains unclear. The i...
Colorectal cancer (CRC) is one of the deadliest tumours, but its pathogenesis remains unclear. The i...
<div><p>Background</p><p>Colorectal cancer (CRC) is one of the deadliest tumours, but its pathogenes...
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide. Lack of specific C...
Long noncoding RNAs (lncRNAs) are transcribed by genomic regions (exceeding 200 nucleotides in lengt...
Alterations in long noncoding RNAs and their mutations have been increasingly recognized in tumoroge...
Background/Aims: Colorectal cancer (CRC) is the third most commonly diagnosed malignancy and the sec...
International audienceAbstract Colorectal cancer (CRC) is one of the most prevalent cancers worldwid...
Colorectal cancer (CRC) is one of the most common malignancies in the world. Easier recurrence and m...
Colorectal cancer (CRC) is one of the most common cancers in humans and a leading cause of cancer-re...
Abstract Background Heterogeneity in colorectal cancer (CRC) patients provides novel strategies in c...
Colorectal cancer (CRC) is one of the most frequent causes of cancer-related death worldwide. The pr...
Altres ajuts: The authors thank Jesse R. Willis for his help in editing the manuscript. TG group ack...
Colorectal cancer (CRC) is the fourth most common cause of death worldwide. Surgery is usually the f...
Colorectal cancer (CRC) is the fourth most common cause of death worldwide. Surgery is usually the f...
Colorectal cancer (CRC) is one of the deadliest tumours, but its pathogenesis remains unclear. The i...
Colorectal cancer (CRC) is one of the deadliest tumours, but its pathogenesis remains unclear. The i...
<div><p>Background</p><p>Colorectal cancer (CRC) is one of the deadliest tumours, but its pathogenes...
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide. Lack of specific C...
Long noncoding RNAs (lncRNAs) are transcribed by genomic regions (exceeding 200 nucleotides in lengt...
Alterations in long noncoding RNAs and their mutations have been increasingly recognized in tumoroge...
Background/Aims: Colorectal cancer (CRC) is the third most commonly diagnosed malignancy and the sec...
International audienceAbstract Colorectal cancer (CRC) is one of the most prevalent cancers worldwid...
Colorectal cancer (CRC) is one of the most common malignancies in the world. Easier recurrence and m...
Colorectal cancer (CRC) is one of the most common cancers in humans and a leading cause of cancer-re...
Abstract Background Heterogeneity in colorectal cancer (CRC) patients provides novel strategies in c...